Delivery Order SPE2DB22D3301-SPE2DB25FY1EQ

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (140 mg/mL SureClick) medication. The contract has a ceiling value of $2,103.96 and a period of performance through February 18, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick medication. The $2,080.33 firm fixed-price contract has a completion date of September 19, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for providing a wide range of medical commodities, including prescription...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,050.46 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Repatha 140 mg/mL SureClick medication. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,103.96, is for the supply of Repatha 140 mg/mL SureClick medication. It is a firm fixed-price contract with a period of performance through March 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.98 firm-fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a $2,103.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a 140 mg/mL SureClick medication, with a period of performance through March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Repatha 140 mg/mL Sureclick medication. The $3,856.92 firm fixed-price contract has a completion date of September 23, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 to provide a broad range of medical commodities, including pharmaceuticals, to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical product Repatha 140 mg/mL SureClick. The contract has a ceiling value of $1,227.31 and a completion date of December 27, 2024. It is a firm-fixed-price delivery order contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a $38,715.92 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Repatha (140 mg/mL SureClick) medication. The contract is not set aside and has an ultimate completion date of September 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical through December 2025...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.38 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of May 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY1EQ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick medication. The contract has a firm fixed price of $1,558.89 and a period of performance through March 10, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is one of many under this overarching IDC contract. The contract does not have a set-aside designation, indicating open competition.

Generated 6/6/25, 9:53 AM